Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.

Abstract

INTRODUCTION Joint arthropathy is the long-term consequence of joint bleeding in people with severe haemophilia. AIM This study assessed change in joint health over time in subjects receiving recombinant factor VIII Fc fusion protein (rFVIIIFc) prophylaxis. METHODS ALONG is the phase 3 pivotal study in which the benefit of rFVIIIFc as a prophylactic… (More)
DOI: 10.1111/hae.13353

Topics

Cite this paper

@article{Oldenburg2017ImprovedJH, title={Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.}, author={Jan Oldenburg and Roshni Kulkarni and Abhishek K Srivastava and Johnny Ndoni Mahlangu and Victor S. Blanchette and E Tsao and Bent Winding and Jennifer Dumont and Neeraj Jain}, journal={Haemophilia : the official journal of the World Federation of Hemophilia}, year={2017} }